Tumor Lymphocyte Infiltration Is Correlated with a Favorable Tumor Regression Grade after Neoadjuvant Treatment for Esophageal Adenocarcinoma.

Haddad, Riad; Zlotnik, Oran; Goshen-Lago, Tal; Levi, Mattan; Brook, Elena; Brenner, Baruch; Kundel, Yulia; Ben-Aharon, Irit; Kashtan, Hanoch

(1) Background: We aimed to explore the association between neoadjuvant treatment, tumor-infiltrating immune lymphocyte (TIL), and tumor-associated macrophage (TAM) and survival in patients with esophageal adenocarcinoma. (2) Methods: Patients who underwent esophagectomy were divided into three groups according to their treatment modality and tumor regression grade (TRG): (i) surgery-only group (SG), (ii) good responders (GR) group (TRG 0–1), and (iii) bad responders (BR) group (TRG 2–3). We then carried out statistical correlations of the immunofluorescence analysis of the immune infiltrate in the esophageal surgical specimens with several clinical and pathological parameters. In addition, we analyzed The Cancer Genomic Atlas (TCGA) dataset for differences in TILs, TAMs, and protein expression in immune pathways. (3) Results: Forty-three patients (SG—15, GR—13, and BR—13) were evaluated. The highest enrichment of CD3 (p < 0.001), CD8 (p = 0.001) and CD4 (p = 0.009) was observed in the stroma of GR patients. On multivariate analysis, only CD8 T cell and signet-ring features were independent prognostic factors for overall survival. In TCGA analysis, we identified overexpression of TAM and colony-stimulating factor 1 receptor (CSF-1R). (4) Conclusions: High enrichment of lymphocyte subpopulations in the microenvironment of esophageal adenocarcinoma is associated with a favorable response to neoadjuvant treatment and an improved patient outcome.

NEOADJUVANT chemotherapy; MACROPHAGE colony-stimulating factor; TUMOR grading; LYMPHOCYTE subsets; STATISTICAL correlation

Journal of Personalized Medicine, 2022, Vol 12, Issue 4, p627

2075-4426

Academic Journal

10.3390/jpm12040627